Загрузка...
Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS
OBJECTIVES: While many axSpA patients, eligible to receive anti-TNFα therapy, derive benefit when prescribed them, some patients do not. The current study aims to identify modifiable targets to improve outcome as well as non-modifiable targets that identify groups less likely to derive benefit. METH...
Сохранить в:
| Опубликовано в: : | Rheumatology (Oxford) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449799/ https://ncbi.nlm.nih.gov/pubmed/31990352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez657 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|